![Anna Sjögren](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Anna Sjögren
Keine laufenden Positionen mehr
Profil
Anna Sjögren worked as Director-Clinical Operations at OxThera AB from 2013 to 2017.
Also worked at Egetis Therapeutics AB as Director-Project & Clinical Development.
Educated at Karolinska Institutet with an undergraduate degree and at the University of Uppsala with an undergraduate degree.
Ehemalige bekannte Positionen von Anna Sjögren
| Unternehmen | Position | Ende |
|---|---|---|
OxThera AB
 OxThera AB Medical/Nursing ServicesHealth Services Develops novel treatments for hyperoxaluria leading to kidney damage and potential organ failure | Corporate Officer/Principal | 01.12.2017 |
| EGETIS THERAPEUTICS AB | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Anna Sjögren
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
5
Beziehungen ersten Grades
4
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Karolinska Institutet
 Karolinska Institutet Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Uppsala
 University of Uppsala Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
OxThera AB
OxThera AB Medical/Nursing ServicesHealth Services Develops novel treatments for hyperoxaluria leading to kidney damage and potential organ failure | Health Services |
Egetis Therapeutics AB
 Egetis Therapeutics AB Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Health Technology |
Wählen Sie MarketScreener 
